Andere Sprachen CardieX Limited

Aktien

A2JN9Z

AU0000015729

CDX

Verzögert Australian S.E. Andere Börsenplätze 04:18:57 06.05.2024			% 5 Tage	% 1. Jan.
0.054 ^AUD	0.00%		-8.47%	-60.00%

02.04.	Australische Aktien geben nach, da der Markt das Protokoll der RBA-Sitzung auswertet	MT
02.04.	Cardiex erreicht zwei Meilensteine auf dem Weg zur Kommerzialisierung der Biomarker-Technologie; Aktien steigen um 5%	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Australian Shares Inch Down As Market Assesses RBA Policy Meeting Minutes	02.04.
Cardiex Marks Two Milestones Toward Wearable Biomarker Technology Commercialization; Shares Up 5%	02.04.
CARDIEX Secures Higher Credit Facility from C2 Ventures	15.03.
CardieX Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29.02.
CardieX Limited Appoints Charlie Taylor as an Independent Non-Executive Director, Effective 1 March 2024	23.02.
CardieX Advances Trade Reinstatement Process with Australian Bourse	02.01.
Cardiex Receives Full Settlement of Clinichain Clinical Trial Payments	07.12.
Cardiex Limited Announces Mitchell Asset Management Extends Loan Expiration of R&D Facility	20.11.
CardieX Limited Announces Resignation of Lesa Musatto as Independent Non-Executive Director	19.10.23
CardieX Limited Announces Sales Results for the First Quarter September 2023	04.10.23
CardieX Limited Announces Resignation of Jarrod White as Interim Chief Financial Officer	28.09.23
CardieX Limited Announces Resignation of Jarrod White as Executive Director	28.09.23
CardieX Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31.08.23
CardieX Limited Announces Executive Changes	30.06.23
CardieX Limited Announces Resignation of Reid Yeoman as CFO	30.06.23
CardieX Limited Provides Revenue Guidance for the Fiscal Year 2023	30.06.23
CardieX Limited announced that it expects to receive AUD 4.1 million in funding	30.06.23
CardieX Limited Receives FDA 510(K) Clearance for its Vascular Biometric Monitor - The CONNEQT Pulse	26.04.23
CardieX Secures US FDA Clearance for Blood Pressure Monitoring Device	26.04.23
CardieX Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28.02.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CardieX Limited

Aktien

A2JN9Z

AU0000015729

CDX

Andere Sprachen

Filter